首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
FUEL INJECTION SYSTEM FOR INTERNAL COMBUSTION ENGINES
摘要
申请公布号
GB2043777(B)
申请公布日期
1982.11.24
申请号
GB19800007216
申请日期
1980.03.04
申请人
BOSCH GMBH ROBERT
发明人
分类号
F02M45/08;F02M47/00;F02M47/02;F02M59/32;F02M61/10;F02M63/02;(IPC1-7):F02M47/02;F02D7/00
主分类号
F02M45/08
代理机构
代理人
主权项
地址
您可能感兴趣的专利
CONTROLLING THE SUCTION PORTS OF A TWO-STROKE ENGINE WITH PISTONS, THE EXHAUST PORTS WITH PISTON
COUNTER ROTATING DISCS FOR CONTROLLING THE SUCTION PROCESS OF A TWO-STROKE ENGINE
FOERGETEG VARIETY OF SPICE GREEN PEPPER WITHOUT SHARPNESS (CAPSICUM ANNUM L. )
LIMTMJ16 VARIETY OF INBRED CORN LINE (ZEA MAYS L.)
SCOOTER WITH SEVERAL FUNCTION
AZOLE COMPOUNDS AND HERBICIDE COMPOSITIONS CONTAINING THEM
DIARYL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
AN ORAL FORMULATION FOR ILEUM ADMINISTERING COMPRISING AN INHIBITOR COMPOUND OF THE ILEAL BILE ACID TRANSPORT
STRAIN SUITABLE FOR PREPARING LIVE ORAL ESCHERICHIA COLI VACCINE FOR PREVENTING WEANING DIARRHOEA OF PIGS, AND METHOD FOR PREPARING THEREOF
ENZYMES OF THE BIOSYNTHETIC PATHWAY FOR THE PRODUCTION OF TRIACYLGLYCEROL AND RECOMBINANT DNA MOLECULES ENCODING THESE ENZYMES
QUINAZOLINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AND PROCESS FOR THEIR PREPARATION
METHOD OF CONTROLLING SUBSCRABER-IDENTIFYING MODUL IN A MOBIL COMMUNICATION TERMINAL, FURTHER MOBIL COMMUNICATION TERMINAL
HCV COMBINATION THERAPY, CONTAINING RIBAVIRIN IN ASSOCIATION WITH ANTIOXIDANTS
FUNGICIDAL MIXTURE HAVING SYNERGISTIC EFFECT AND ITS USE
C7 CARBONATE SUBSTITUTED TAXANES AS ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AZEOTROPE-LIKE COMPOSITION COMPRISING 1,1,1,3,3-PENTAFLUOROBUTANE AND ITS USE
MACROMOLECULAR PHOTOCROSSLINKERS, THEIR USE, PROCESS FOR PREPARATION OF CROSSLINKED STRUCTURE FROM COMPOSITION CONTAINING THE SAME AND OPHTHALMIC COMPOSITION CONTAINING THE SAME
BLOCKING ARRANGEMENT
METHOD FOR PRODUCING L-PHOSPHINOTHRICINE BY ENZYMATIC TRANSAMINATION WITH ASPARTATE
C16 UNSATURATED PROSTAGLANDIN ANALOGS AND THEIR USE